Patient must have received one or more prior therapies for Chronic Lymphocytic Leukemia Patients may have received any of the following prior treatment regimens fludarabine-containing combinations alemtuzumab single agent or combination rituximab combinations chlorambucil cyclophosphamide prednisone or other forms of 